An expert panel discusses where bempedoic acid currently fits into the treatment of hypercholesterolemia.
Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC
Advertisement
Articles by Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC
An overview of the REDUCE-IT trial of icosapent ethyl for the management of triglycerides and prevention of cardiovascular events.
The role of ezetimibe and PCSK9 inhibitors as treatment for patients who are statin intolerant or require add-on therapy to help reduce cholesterol levels.
The standard of care for managing high cholesterol levels.
The value of interdisciplinary research and multidisciplinary care of patients at high risk for cardiovascular events.
Advertisement
Latest Updated Articles
Strategies Used to Treat HypercholesterolemiaJanuary 14th 2022
- Multidisciplinary Approaches to Reducing CVD Risk
January 14th 2022
Advertisement
Advertisement
Trending on Drug Topics
1
Recombinant Shingles Vaccine May Lower Cardiovascular Risk
2
Updated Guideline Refines Approach to Migraine Prevention in Adults
3
Pharmacy Leaders Set Priorities for Global Primary Care Integration
4
Digital Outreach Improves Statin Adherence in High-Risk Patients
5